Correction: End-ischemic hypothermic oxygenated perfusion for extended criteria donors in liver transplantation: a multicenter, randomized controlled trial—HOPExt

Trials

Correction

Pierre Pradat¹  Solene Pantel¹  Sylvie Thevenon¹  Marianne Maynard¹  Mickaël Lesurtel²  Jean-Yves Mabrut²  Kayvan Mohkam²  Emmanuel Boleslawski³  Philippe Bachellier⁴  François Faitot⁴  Olivier Soubrane⁵  Mircea Chirica⁶  Marc-Antoine Allard⁷  Rene Adam⁷  Olivier Scatton⁸  Michel Rayar⁹  Fabien Robin⁹  Laure Lalande^1,10 

[1] Centre for Clinical Research, Hospices Civils de Lyon, Croix-Rousse University Hospital, Lyon, France;Department of Digestive Surgery and Liver Transplantation, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France;Department of HPB Surgery and Liver Transplan- Tation, Claude Huriez University Hospital, Lille, France;Department of HPB Surgery and Liver Transplanta- Tion, Hautepierre University Hospital, Strasbourg, France;Department of HPB Surgery and Liver Transplantation, Beaujon University Hospital, Clichy, France;Department of HPB Surgery and Liver Transplantation, Michallon University Hospital, Grenoble, France;Department of HPB Surgery and Liver Transplantation, Paul Brousse University Hospital, Villejuif, France;Department of HPB Surgery and Liver Transplantation, Pitié Salpêtrière Hospital, Paris, France;Department of HPB Surgery and Liver Transplantation, Pontchaillou Univer- Sity Hospital, Rennes, France;Department of Pharmacy, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France;

关键词: ;   

DOI  :  10.1186/s13063-023-07471-1

来源: Springer

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023